Embold Therapeutics

Ownership

Public

Employees

~100

Stage

Preclinical

Modalities

Protein therapeutics

Embold Therapeutics General Information

Early-stage company developing enzyme therapeutics for neurodegenerative disorders

Contact Information

Website

Primary Industry

Biotech

Corporate Office

Redwood City, California
United States

Drug Pipeline

No pipeline data available

For full access to Embold Therapeutics's pipeline data

Key Partnerships

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Embold Therapeutics Funding

Deal Type	Date	Amount	Status	Stage

Early Stage VC (Series A)	04-Jun-2020	$38M	Completed	Phase 1
Seed Round	12-Feb-2019	$8.5M	Completed	Startup

Interested in comprehensive profile data?

We'll help you find what you need

To view Embold Therapeutics's complete valuation and funding history, request access »